PROLONGED hypotension may be a consequence of (1) decreased vasoconstrictor tone in the peripheral vasculature, (2) treatment was given. Subsequently she received 3 grains of thyroid extract daily. No evidence of metastasis was ever found. Two years later the patient was admitted to the hospital because of vaginal spotting, for which dilatation and curettage were performed. A sulfobromophthalein test was done at this time without adverse effects. For several years prior to the present hospital admission the patient had been under medical care for peptic esophagitis. There was no past history of allergic phenomena.
Physical examination on admission revealed a well-developed white woman in no acute discomfort. Her blood pressure was 150/100 mm. Hg sitting and 130/90 mm. Hg standing. The pulse rate was 72 beats per minute, and her temperature was 98.8F. Examination of the head, ears, eyes, nose, and throat was not remarkable. The thyroid gland was not palpable, and there was no adenopathy. The lung fields were clear. The heart rhythm was regular, and no murmurs were heard. No masses or organs were palpated in the abdomen. There was mild right lower quadrant abdominal tenderness. Small external hemorrhoids were present, without evidence of bleeding. No stool was obtained on the initial rectal examination.
The hemoglobin was 14.7 Gm. per cent; the hematocrit value was 46 per cent. The white blood-cell and differential counts were normal. A urinalysis was negative except for a trace of albumin. The blood urea nitrogen, fasting blood sugar, serum calcium and phosphorus, alkaline phosphatase, and serum bilirubin determinations were normal.
One day after admission the patient was given . 5 On the twenty-seventh day after the onset of hypotension the patient was given 10 mg. of guanethidine * intramuscularly. It was considered that the action of metaraminol might be potentiated by guanethidine. Six and one-half hours later the blood pressure could be maintained by one half of the previously required dosage of metaraminol solution. In 24 hours, however, the patient again required the previous dosage of vasopressor to maintain the blood pressure. Twenty milligrams of guanethidine given intramuscularly at this time had no further discernible effect.
The patient's clinical status continued without significant change. Nethalide, 150 mg. orally every 6 hours, was begun 32 days after the onset of hypotension. The rate of metaraminol infusion was kept constant at 16 drops per minute. Thirteen hours later it became possible to halve the metaraminol concentration-from 100 mg. to 50 mg. in 1,000 ml. of 5-per cent glucose in water.
Twelve hours later the concentration was again halved, and 24 hours later (2 days after nethalide was begun) the metaraminol solution could be stopped. There was no evidence of postural hypotension. Six days after the nethalide was started it was discontinued abruptly without adverse effects. The prednisone dosage was then tapered down and stopped.
Just before the nethalide was started the pa- 
Patient 2
A 53-year-old Caucasian housewife was admitted to the hospital after the acute onset of anterior chest pain and shortness of breath. There was a history of anticoagulant therapy subsequent to previous hospitalization for an impending myocardial infarction.
Physical examination revealed a well-developed white woman whose sensorium was dulled because of the earlier administration of morphine sulfate. Her blood pressure was 130/90 mm. Hg. The pulse rate was 75 beats per minute. The respiratory rate was 30 per minute, and her temperature was 98.4F. Her pupils were pinpoint in size. There was no adenopathy. The chest was clear. The heart rhythm was regular, and no murmurs were audible. The abdomen was soft; no organs were palpated. The rest of the general physical examination was negative.
The initial hemoglobin concentration was 15. 
Discussion
It has recently been emphasized that prolonged hypotension, especially after myocardial infarction, is critically related to the effective circulating blood volume.2 Others < have noted that the efficacy of norepinephrine and metaraminol in the treatment of cardiogenie shock and hypotension may be in part related to their venoconstrictor action. The rise in hemoglobin concentration after the onset of hypotension seen in both patients here presented probably was due to a decrease in circulating blood volume. The fall in plasma volume was confirmed in the first patient. No attempt was made to correct this deficit. Instead, a specific pharmacologic attempt was made to study the sympathetic nervous system in both patients.
The first patient, the fifteenth reported case of severe systemic anaphylactoid reaction to sulfobromophthalein,4-6 illustrates once more that this compound is potentially hazardous. The failure to demonstrate circulating precipitins by the Ouchterlony technic is not surprising in view of the low molecular weight of sulfobromophthalein. The cause of the hypotension in the second patient is less evident. Because of the character and location of the chest pain and the enzyme changes, a myocardial etiology was initially suspected. In view of the continued hypotension, the clinical picture, and the good pressor response to small doses of metaraminol, a peripheral origin for the hypotension was then considered more likely.
Studies in animals and man 9 indicate that the pressor activity of norepinephrine is potentiated by guanethidine. Corcoran et al.1"' reported the potentiation of the pressor response to norepinephrine by a small dose of guanethidine in a patient in severe shock with staphylococcal enteritis. Although the delayed potentiating response to intramuscular guanethidine in our first patient may have been due to the release of bound endogenous catecholamines, the persistence of the poten-tiating effect for 24 hours suggests another mechanism. A direct action of guanethidine on receptor substance that increases sensitivity to various amines merits consideration.
The most tenable theory for adrenergic cellular receptor mechanisms is Ahlquist's.' Two types of receptors are distinguished: (1) alpha receptors associated with sympathetic excitatory functions such as vasoconstriction, and stimulation of the uterus, nicitating membrane and dilator pupillae, and (2) ous system homeostasis was quickly obtained, and exogenous vasopressors were no longer needed. For reasons presently unknown, this homeostasis was subsequently unaltered when nethalide was discontinued. Though the proposed negative inotropism of any betareceptor blocking agent might be expected to have a detrimental effect in patients with prolonged hypotension, the results in our two patients indicate otherwise. Preliminary hemodynamic observations in three patients (two of whom were hyperthyroid) have not revealed a significant fall in cardiac output following intravenous nethalide. 13 It remains possible that the response in both our treated patients was unrelated to the known properties of nethalide.
A further consideration is that these patients may have been partly depleted of norepinephrine as a consequence of the metaraminol therapy. This would not be inconsistent with the hypothesis of relative peripheral adrenergic beta-receptor dominance and may have served to contribute to that state.
The reticulocytosis is of interest. Four other patients, not in clinical shock, also received nethalide for an average period of 6 days. No polychromatophilia or change in hemoglobin concentration was observed. A drug-induced hemolytic anemia in the present two patients, however, remains a possibility. It is also possible that in the presence of prolonged hypoxia, a consequence of the hypotension, erythropoiesis was stimulated by erythropoietin. Also, it is conceivable that diminished arterial perfusion of the bone marrow in prolonged hypotension is itself a bone marrow stimulus.
Summary
Two patients with prolonged hypotension requiring continuous vasopressor therapy are described.
In both patients treatment with nethalide, a beta-receptor blocking agent, appeared clinically effective in allowing the withdrawal of metaraminol therapy and the maintenance of normotension. The results in these patients tend to fortify a hypothesis of peripheral adrenergic beta-receptor dominance in patients with prolonged hypotension.
